CORONARY ANGIOPLASTY IN MULTIVESSEL DISEASE: REAL-LIFE INSIGHTS AND CLINICAL IMPLICATIONS

Main Article Content

Farid Ullah1, Anurag Rawat2, Dr. Fatima Tariq 3, Bryan O. Oyarebu4, Goodness Ebere Onyeukwu5, Huzifa Abdalla Abdelrahman Ahmed6, Dr. Asmat Mustafa Memon7, Shireen Farrukh8

Keywords

Coronary artery bypass grafting (CABG), Fractional flow reserve (FFR), Functional revascularization, Angiographic findings, All-cause mortality, Recurrent revascularization, Myocardial infarction, Cerebrovascular accident (CVA)

Abstract

The study evaluates medium-term outcomes of coronary angioplasty in patients with multivessel coronary artery disease (CAD) in real-life conditions. While coronary artery bypass grafting (CABG) has been the gold standard for severe multivessel lesions, advancements in technology and pharmacology have made angioplasty a viable option. Functional revascularization, guided by fractional flow reserve (FFR), challenges the traditional notion of multivessel status, prioritizing functionally optimal over angiographically complete revascularization.


Methods: A retrospective analysis of patients with multivessel CAD admitted between January 2006 and December 2010 was conducted. Inclusion criteria comprised significant stenosis in at least two major coronary arteries, while those with prior CABG or angioplasty were excluded. Patient demographics, angiographic findings, and clinical outcomes were collected via phone interviews, medical records, and consultation.


Results: Key cardiac events during follow-up included all-cause mortality, recurrent revascularization (surgical or percutaneous), myocardial infarction (with or without Q wave), and cerebrovascular accident (CVA).


Conclusion: The study aims to provide insights into the efficacy and safety of coronary angioplasty as a treatment option for patients with multivessel CAD in real-world settings

Abstract 159 | PDF Downloads 65

References

Appleby, C. E., Mackie, K., Džavík, V., & Ivanov, J. (2010). Late outcomes following percutaneous coronary interventions: results from an extensive, observational registry. Canadian Journal of Cardiology, 26(7), e218-e224.
Aragão, I., Peixoto, E., Peixoto, R., Simões, S., Marcolla, V., Spritzer, T., Ferreira, P., Santos, C., Macêdo, T., & Anjos, I. (2018). PO155 Primary Percutaneous Coronary Intervention and Biological Sex Influence. Independent Risk Factors For Death And Major Events After Immediate and Medium-Term Follow-Up. Global Heart, 13(4), 415-416.
Brueren, B. R. G. (2005). Percutaneous coronary interventions in the real world: lessons from the nineties.
Cui, K., Lyu, S., Song, X., Liu, H., Yuan, F., Xu, F., Zhang, M., Wang, W., Zhang, M., & Zhang, D. (2019). Drug-eluting stent versus coronary artery bypass grafting for diabetic patients with multivessel and left central coronary artery disease: a meta-analysis. Angiology, 70(8), 765-773.
De Cannière, D., Jansens, J.-L., Goldschmidt-Clermont, P., Barvais, L., Decroly, P., & Stoupel, E. (2001). Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting. American Heart Journal, 142(4), 563-570.
Gagnor, A., Tomassini, F., Cerrato, E., Rolfo, C., Gambino, A., Giolitto, S., Favro, E., Bollati, M., Tizzani, E., & Varbella, F. (2015). Unprotected Left-Main Coronary Angioplasty in the Elderly in a High Volume Catheterization Centre without On-Site Surgery Facilities: Immediate and Medium Term Outcome—The Old-Placet Registry. Advances in Vascular Medicine, 2015.
Hlatky, M. A., Boothroyd, D. B., Melsop, K. A., Brooks, M. M., Mark, D. B., Pitt, B., Reeder, G. S., Rogers, W. J., Ryan, T. J., & Whitlow, P. L. (2004). Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation, 110(14), 1960-1966.
JIMÉNEZ‐NAVARRO, M. F., ALONSO‐BRIALES, J., HERNÁNDEZ‐GARCÍA, J. M., Curiel, E., Kühlmorgen, B., GÓMEZ‐DOBLAS, J. J., GARCÍA‐PINILLA, J. M., Robledo, J., & De Teresa, E. (2006). The usefulness of fractional flow reserve in multivessel coronary artery disease with intermediate lesions. Journal of Interventional Cardiology, 19(2), 148-152.
Jurado-Román, A., López-Melgar, B., García-Tejada, J., Hernández-Hernández, F., Velázquez-Martín, M. T., Albarrán-González-Trevilla, A., Rubio-Alonso, B., Díaz-Anton, B., Andreu-Dussac, J., & Tascón-Pérez, J. C. (2013). Percutaneous coronary intervention in Porto-ostial lesions. Immediate and medium-term results in a real-world cohort. International Journal of Cardiology, 168(3), 3067-3069.
Korotkikh, A., Babunashvili, A., Kaledin, A., Akhramovich, R., Derkach, V., Portnov, R., Kartashov, D., & Kazantsev, A. (2023). Distal radiation access as an alternative to conventional radial access for coronary angiography and percutaneous coronary interventions (according to the TENDERA trial)—Current Problems in Cardiology, 48(4), 101546.
Lee, M. S., Kapoor, N., Jamal, F., Czer, L., Aragon, J., Forrester, J., Kar, S., Dohad, S., Kass, R., & Eigler, N. (2006). Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left central coronary artery disease. Journal of the American College of Cardiology, 47(4), 864-870.
Lee, W.-C., Tsai, T.-H., Chen, Y.-L., Yang, C.-H., Chen, S.-M., Chen, C.-J., Lin, C.-J., Cheng, C.-I., Hang, C.-L., & Wu, C.-J. (2014). Safety and feasibility of coronary stenting in unprotected left primary coronary artery disease in the actual world clinical practice—a single center experience. PloS one, 9(10), e109281.
Lettieri, C., Savonitto, S., De Servi, S., Guagliumi, G., Belli, G., Repetto, A., Piccaluga, E., Politi, A., Ettori, F., & Castiglioni, B. (2009). Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome. American Heart Journal, 157(3), 569-575. e561.
Loebe, M., Potapov, E. V., Hummel, M., Weng, Y., Bocksch, W., & Hetzer, R. (2000). Medium-term results of heart transplantation using older donor organs. The Journal of heart and lung transplantation, 19(10), 957-963.
Millan‐Iturbe, O., Sawaya, F. J., Lønborg, J., Chow, D. H., Bieliauskas, G., Engstrøm, T., Søndergaard, L., & De Backer, O. (2018). Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: real‐world results from the East Denmark Heart Registry. Catheterization and Cardiovascular Interventions, 92(4), 818-826.
Park, D.-W., Kim, Y.-H., Yun, S.-C., Lee, J.-Y., Kim, W.-J., Kang, S.-J., Lee, S.-W., Lee, C.-W., Kim, J.-J., & Choo, S.-J. (2010). Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left central coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN–MAIN (ASAN Medical Center–Left MAIN Revascularization) Registry. Journal of the American College of Cardiology, 56(17), 1366-1375.
Sionis, D. G. (2005). The Use of Drug-Eluting Stents in Everyday Clinical Practice: Can the Results of Randomised Trials be Achieved in the "Real World"? Hellenic J Cardiol, 46, 124-127.
Valgimigli, M., Dawkins, K., Macaya, C., de Bruyne, B., Teiger, E., Fajadet, J., Gert, R., De Servi, S., Ramondo, A., & Wittebols, K. (2007). The impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents is a subanalysis of the ARTS II trial. Journal of the American College of Cardiology, 49(4), 431-441.
Van Wyk, J. (2009). The synergy between percutaneous coronary intervention with TAXUS and cardiac surgery study: a surgical perspective: SYNTAX study. SA Heart, 6(4), 230-235.
Varani, E., Balducelli, M., Aquilina, M., Vecchi, G., Hussien, M. N., Frassineti, V., & Maresta, A. (2008). Single or multivessel percutaneous coronary intervention in ST‐elevation myocardial infarction patients. Catheterization and Cardiovascular Interventions, 72(7), 927-933.